Cardlytics Q4 2023 Earnings Report
Key Takeaways
Cardlytics reported an 8.1% increase in total revenue to $89.2 million for Q4 2023, compared to $82.5 million in Q4 2022. The company's net loss attributable to common stockholders was $(100.8) million, or $(2.56) per diluted share, compared to a net loss of $(378.3) million, or $(11.32) per diluted share in Q4 2022. Adjusted EBITDA was $10.0 million, a $16.1 million increase compared to $(6.1) million in Q4 2022.
Total revenue increased by 8.1% to $89.2 million.
Billings increased by 4.6% to $131.9 million.
Net loss attributable to common stockholders was $(100.8) million, or $(2.56) per diluted share.
Adjusted EBITDA improved by $16.1 million to $10.0 million.
Cardlytics
Cardlytics
Forward Guidance
Cardlytics anticipates billings, revenue, adjusted contribution and adjusted EBITDA to be in the following ranges for Q1 2024: Billings $105.0 - $109.0 million, Revenue $70.0 - $73.0 million, Adjusted Contribution $37.0 - $39.0 million, Adjusted EBITDA ($1.0) - $1.0 million.